OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/09/2026
Back to search
Official data from USPTO
TRANSFUSIUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TRANSFUSIUS
ST13
US500000079407821Class
5, 35, 42, 44
Filing
79407821
Registration
7910357
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/10/2026
Trademark type
Word
Nice classes
5, 35, 42, 44
Filing date
06/21/2024
Registration date
08/26/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/26/2025
Last transaction
04/10/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
CORWIN, KEVIN SCOTT
Law office
M30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Haema GmbH
Haema AG
Representatives
Deborah L. Shapiro Moses & Singer LLP
Technical classification
Nice Classes
Class 5Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drugsin particular medicines made from blood componentsfractions and preparationswith said medicines being for the treatment of diseases and disorders of the blood; Living cells and cell fragments for medical purposesred blood cell concentrates; Living cells and cell fragments for medical purposesplatelet concentrates; Living cells for medical purposesleukocyte preparations of white bloods cells for medical purposes; blood plasmablood for medical and medical diagnostic purposes; blood cells for medical purposes; Blood componentsfractions and preparationsblood for medical purposesblood plasmablood substitutes for human use; Blood componentsfractions and preparations for injectionblood for medical purposesblood plasmablood substitutes for human use; Blood componentsfractions and preparations for automatic transplantationblood for medical purposesblood plasmablood substitutes for human use; Blood componentsfractions and preparations for transfusionblood for medical purposesblood plasmablood substitutes for human use; Blood componentsfractions and preparations for immunotherapyblood for medical purposesblood plasmablood substitutes for human use; Blood componentsfractions and preparations for autologous transfusionblood for medical purposesblood plasmablood substitutes for human use; Bloodblood fractions and blood components for medicaltherapeuticprophylactic purposesblood for medical purposesblood plasmablood substitutes for human use; Blood components for medical useblood plasmablood substitutes for human use; Blood plasma; Cells for medical useblood cell preparations; Sanitary preparations for medical purposes; Finished medical productshuman blood for medical purposes and blood plasma; Pharmaceutical preparations for the treatment of bleeding disordersheart diseasecancer; Immunotherapeutic and immunoprophylactic preparations in the nature of blood componentsfractions and preparations for immunotherapyblood for medical purposesblood plasmablood substitutes for human use; Living cells for medical purposesleukocyte preparations; Living cells and cell fragments for medical purposesplatelet and red blood cell concentratesquarantine plasmafractionated plasma; clinical medical reagents for processing human blood and blood components for use in blood transfusions and for extracorporeal blood processing stored in bagsbottlessyringes and similar containers for storing substances such as these for medical purposes; Pharmaceutical products and preparationsin particular infusion and transfusion solutions in the nature of bloodblood plasmabloods substitutes for human use and pharmaceutical preparations for the treatment of blood diseases and disorders; Pharmaceutical blood plasma preparations for the treatment of blood diseasesblood disorders; Pharmaceutical blood preparations for the treatment of blood diseasesblood disorders; Pharmaceutical blood productspharmaceuticals for the treatment of blood diseasesblood disorders; Cell material for autotransplantation and autotransfusioncells for medical use; Cell material for transplantation and transfusioncells for medical use; Cell material for medicaltherapeutic and prophylactic purposescells for medical purposes
Class 35
Advertising services; Arranging advertising eventsorganizing events for advertising purposes; Advertising services for othersdeveloping advertising campaigns for others for attracting donors of blood and blood components; Advertising services to create brand identity for others in all mediaincluding radiotelevisioncinemaprintvideotexton-line and via teletext advertising; Promoting the goods and services of others by arranging for sponsors provide promotional sponsorships by affiliating their goods and services with sports exhibitionsart showslive music concerts
Class 42
Technical provision and support for data processing systemsproviding technology information in the field of data processing and technical support services in the nature of troubleshooting computer software problems in connection with data processing; Providing temporary use of onlinenon-downloadable software for accessing patient treatment databases and donor databases; Providing technological and scientific information about scientific laboratory services and blood banksin particular medical research laboratories; Providing of scientific information derived from analysis of medical diagnostic results; Blood analysis services for scientific research purposes; Scientific laboratory services; Chemical laboratories and medical research laboratories; Scientific research in the field of physics; Chemistry serviceschemical analysischemical laboratories; Chemical analysis; Scientific testing servicesblood testing for scientific research purpose; Blood testing for scientific research purposeswith said testing entailing the filtrationseparation and centrifugation of blood; Laboratory trialsmedical and scientific research in the nature of conducting clinical trials for others; Development and further development of data processing computer software and hardware in the field of laboratory medicine and blood and plasma collection; Database development servicescreation of medical databases in digital form; Scientific and medical research in the medical and pharmaceutical fields; Scientific and medical research in the field of chemistry and biology; Development and establishment of testing specifications and procedures for the medical industrydevelopment of medical equipment procedures and test proceduresdonation proceduresmedical instrument procedures; Data processing servicestechnical and scientific registration and processing of patient treatment data and donor data in databases; Scientific laboratory services
Class 44
Medical analysis services for diagnostic and treatment purposes provided by medical laboratories in connection with blood and plasma donation and clinical medical consultations in connection with the same; Pharmacy adviceproviding medical advice in the field of pharmaceuticals; providing of medical information in relation to blood donation centres; Providing of medical and pharmaceutical support via telephoneproviding medical information; Medical services featuring blood fractionation or blood transfusion for medical purposes; Medical services in the nature of blood sampling or collection; Blood examination in the nature of medical blood analysis services for diagnostic treatment purposes; medical assistance; blood bank services; Blood bank services in the nature of blood donation centres; Blood bank services in the nature of blood extraction stations; Services in the field of immunotherapymedical care; Nursing home services; Medical careimmunotherapy; Providing medical informationmedical diagnostic information through medical results; Medical careconducting medical diagnostics within the framework of conducting medical examinations; Blood bank servicesconducting of blood donationincluding platelet donationsSDR donation being erythrocytewhole blood donationplasma donationautologous donation being multiple type of cellular donations from an individual; Medical careexecution of medical and clinical examination services; nutrition consultation; Providing medical opinions in the nature of medical advice in the field of weight lossdermatologyhematology; health counseling; Medical servicestransfusion or transplantation of blood and blood components; Medical services; Rental of medical equipment; Rental of medical equipment in the nature of medical diagnostic instruments and apparatus for medical purposes
Publications
History of USPTO decisions and trademark events.
26 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/02/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/23/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/23/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/14/2026
FIMP
FINAL DISPOSITION PROCESSED
03/14/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/26/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/26/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/26/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/08/2025
PUBO
PUBLISHED FOR OPPOSITION
07/08/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/02/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/18/2025
RFNT
REFUSAL PROCESSED BY IB
02/22/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/04/2025
RFRR
REFUSAL PROCESSED BY MPU
02/04/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/31/2024
CNRT
NON-FINAL ACTION WRITTEN
12/30/2024
DOCK
ASSIGNED TO EXAMINER
12/21/2024
MAFR
APPLICATION FILING RECEIPT MAILED
10/28/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/28/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/24/2024
Continuous trademark protection
Get notified about every new filing that threatens TRANSFUSIUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.